KNOWLEDGE BANK

Interviews

Ensuring Ethics in AI-Driven Drug Safety

Senior Director of Pharmacovigilance and Risk Management at Curis Inc.
Ashish Jain is Senior Director of Pharmacovigilance and Risk Management at Curis Inc with over years of experience in drug safety He is also leading the Innovation Working Group at the North American Society of Pharmacovigilance NASoP his expertise in combining technological innovation with patient safety makes him uniquely qualified to address the ethical challenges of AI implementation in pharm...

Articles

Artificial Intelligence in Oncology

Cancer is the most prevalent cause of death across the globe According to the World Health Organization there is an estimated increase from the anticipated million cases of cancer in It is predicted that more than million

Research Insights

Spectrophotometric determination of Ethionamide in Pharmaceuticals using Folin-Ciocalteu reagent and Iron (III)-Ferricyanide as Chromogenic Agents

Abstract Two simple and sensitive spectrophotometric methods are described for the determination of ethionamide ETM in pure drug and tablets The first method is based on the reduction of FolinCiocalteu FC reagent by ETM in sodium carbonate medium to form a blue coloured complex which was measured at nm Molybdenumtungsten blue method In the second me

Case Studies

Variation In Adverse Drug Reactions Listed In Product Information For Antidepressants And Anticonvulsants, Between The Usa And Europe: A Comparison Review Of Paired Regulatory Documents

Abstract Objective To compare consistency of adverse drug reaction ADR data in publicly available product information documents for brand drugs between the USA and Europe and to assess the usefulness of information for prescribers and patients Design A comparison review of product info

Techno Trends

Deciphera Pharmaceuticals’ Develops QINLOCK™ (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumors in Adults

Deciphera Pharmaceuticals developed QINLOCK ripretinib mg capsules to treat adult patients with advanced gastrointestinal stromal tumour GIST who underwent prior treatment with three or more kinase inhibitors including imatinib

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

TOP ARTICLES

1

Significance of Bioinformatics in Precision Oncology

Pravitha Kasu Sivanandan

Pravitha Kasu Sivanandan holds an MSc in Bioinformatics from Bharathiyar University, India, and works as a Bioinformatician at MVR Cancer Centre & Research Institute. She specializes in multi-omics data analysis, focusing on stratified healthcare. She focuses on potential of bioinformatics in precision oncology. Pravitha is also an Associate Member of AACR.

 

2

Design of Self-antibacterial and Biocompatible Titanium Surfaces for Biomedical Applications

Lalit M. Pandey

Lalit M Pandey is an Associate Professor at the Department of Biosciences and Bioengineering, IIT Guwahati. His main research interests include biointerfaces and biomaterials, biochemical engineering, and environmental biotechnology. He has published over hundred research articles in international journals and serves on the editorial board of six international journals. He is serving as Associate Editor in Frontiers in Bioengineering and Biotechnology. He has co-edited three books. He is a life member of the International Association of Engineers (IAENG), the National Academy of Sciences (NASI), the Indian Institute of Chemical Engineers (IIChE), the Biotech Research Society, India (BRSI), and Nano and Molecular Society (India) and serves as a reviewer for several peer-reviewed journals.

 

3

Accelerating the Medical Writing Process with Automation From research to publication

Nirupama Parate

Nirupama Parate a Senior Associate at Freyr Solutions’ Medicinal Products Division is an MBA Pharmaceutical Tech graduate and has a knack for Medical Writing Automation. She holds experience across pharmaceutical and medical devices ranging from Regulatory Affairs, pharmaceutical marketing and communications, and medical writing automation. She strongly believes in walking the extra mile and adding a personal touch to everything she does.

 

4

Kinase Inhibitors as Antiviral Agents

Thanigaimalai Pillaiyar

Thanigaimalai Pillaiyar is working as an independent junior research group leader and establishing a research group at the Tübingen Center for Academic Drug Discovery (TüCAD2), University of Tübingen. His research interests include medicinal chemistry of orphan G protein-coupled receptors (GPCRs), synthetic organic chemistry, and dual SARS-CoV-2 Mpro-kinase inhibitors.

 

Stefan Laufer

Stefan Laufer is Professor for Pharmaceutical/Medicinal Chemistry at Tuebingen University and chairs the TüCAD2. His research interests are anti inflammatory and cancer drug discovery. He authored more than 500 publications, 15 books/book chapters and is inventor in 42 patent families with >330 national applications. 4 compounds from his lab made it to first into man studies.

 

5

The Rapidly Evolving Landscape of Cancer Therapeutics

Rajesh Kumar

Rajesh Kumar is an Assistant Professor of Pharmaceutical Sciences at Kerala University of Health Sciences, India. He has been teaching Diploma, Bachelor, and Doctor of Pharmacy students for several years and is actively involved in research. He has authored more than 19 papers and is a reviewer for Bentham Science Publishers. His research includes applying the principles of pharmaceutical sciences, omics technologies, computational biology, and bioinformatics in the broad areas of cancer research, ethnopharmacology, drug delivery, targeting, and formulations.

 

Seetha Harilal

Seetha Harilal is an Assistant Professor of Pharmacology at Kerala University of Health Sciences, India. She has several years of experience in teaching Diploma, Bachelor, and Doctor of Pharmacy students and is actively pursuing research. She has authored more than 22 papers and is a manuscript reviewer for Bentham Science Publishers, Frontiers in Public Health, Frontiers in Medicine, and Archives of Medical Research (Elsevier). Her research includes the diverse areas of pharmacology and therapeutics, phytopharmaceuticals, cancer research, neurological disorders, and the application of omics technologies, computational pharmacology, and bioinformatics.

 

press releasesRead more...

Lonza Expands Strategic Collaboration with Leading US Biopharmaceutical Company

Lonza the worlds leading contract development and manufacturing organization CDMO today announced an expanded strategic collaboration with a leading USbased biopharmaceutical company

Cartherics recognised as Asia Pacific Emerging Leader in Allogeneic Cell Therapy

Cartherics Pty Ltd Cartherics or Company a biotechnology company developing offtheshelf immune cell therapies focusing on highimpact womens diseases with lead programs in ovarian cancer and endometriosis

Icosagen completes €45 million expansion, bringing therapeutic protein discovery, development and GMP manufacturing together under one roof

Estoniabased biotechnology company Icosagen has completed a major strategic expansion to strengthen its integrated biologics development and manufacturing capabilities at a single site creating a seamless pathway

AGC Biologics Expands to Fill-Finish in U.S. Through Strategic Partnership with Pyramid Pharma Services

Drug developers have a new optimized option for USbased manufacturing as AGC Biologics enters a strategic partnership with Pyramid Pharma Services The collaboration combines AGC Biologics expertise

Vect-Horus announces collaboration and license option agreement with Servier to develop targeted oligonucleotide therapeutics for rare CNS diseases

VectHorus a privately held biotechnology company that designs and develops molecular vectors facilitating the targeted delivery of therapeutic molecules and imaging agents announces a research evaluation and exclusive

FDA grants Priority Review to Roche’s Enspryng, the first and only at-home subcutaneous treatment option for thyroid eye disease (TED)

Roche announced today that the US Food and Drug Administration FDA has accepted and granted priority review to a supplemental Biologics License Application sBLA for Enspryng satralizumab

EventsRead more...

07 - 09

Jul 2026

The Pharma India Expo 2026

Bombay Exhibition Centre, Mumb...

07 - 09

Jul 2026

08 - 10

Jul 2026

CPHI SEA 2026

QSNCC, Bangkok, Thailand

09 - 11

Jul 2026

Pharma Pro&Pack Expo 2026

HITEX Exhibition Centre, Hyder...

16 - 19

Jul 2026

Bio Asia Taiwan 2026

Taipei Nangang Exhibition Cent...

20 - 22

Jul 2026

6th mRNA-Based Therapeutics Summit

The Westin Boston Seaport Dist...

20 - 22

Jul 2026

24 - 25

Jul 2026

LATEST NEWSRead more...

Viva Biotech and Adjutor Group Partner to Expand Global Drug Development Services

Viva Biotech and Adjutor Group have announced a collaboration aimed at expanding their international business networks and strengthening engagement with global life sciences partners

Excalipoint Therapeutics partners with Roche to evaluate EXP011 in DLL3-expressing solid tumours

Excalipoint Therapeutics has entered into a clinical trial collaboration with Roche to evaluate its lead product candidate EXP CTM in combination with atezolizumab for the treatment of DLLexpressing solid tumours

Innovent Biologics and Lilly sign commercialisation agreement for Verzenios in mainland China

Innovent Biologics and Eli Lilly and Company have signed a distribution and promotion agreement for Verzenios abemaciclib in mainland China

Roche launches AXELIOS 1 next-generation sequencing platform

Roche has launched AXELIOS its nextgeneration sequencing platform powered by proprietary Sequencing by Expansion SBX technology The new system combines high accuracy rapid sequencing flexibility

Ipsen to acquire Kartos Therapeutics, expanding late-stage haemato-oncology pipeline

Ipsen has entered into a definitive merger agreement to acquire Kartos Therapeutics strengthening its latestage haematooncology pipeline The acquisition adds navtemadlin an investigational MDM inhibitor

Ionis Licenses Zilganersen Rights Outside US to Recordati

Ionis Pharmaceuticals has signed a licensing agreement with Recordati granting the company exclusive rights to develop and commercialise the investigational medicine zilganersen for Alexander disease AxD